Literature DB >> 4514979

Congenital neutropenia: in vitro growth of colonies mimicking the disease.

P L'Esperance, R Brunning, R A Good.   

Abstract

Congenital neutropenia is a lethal disease characterized by recurrent infections beginning in the neonatal period, absence of neutrophils in the peripheral blood, eosinophilia, and monocytosis. The bone marrow shows an apparent "maturation arrest" of the neutrophil series at the promyelocyte stage. Granulocytic colonies grown in vitro in soft agar medium show normal development of eosinophilic colonies and monocyte-macrophage colonies, but defective neutrophil maturation. The abnormal colonies observed contained only myeloblasts and promyelocytes. Thus, it seems to have been possible to mimic in vitro the abnormal differentiation that is observed in vivo.

Entities:  

Mesh:

Year:  1973        PMID: 4514979      PMCID: PMC433331          DOI: 10.1073/pnas.70.3.669

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  THE EFFECT OF ERYTHROPOIETIC STIMULATION ON THE HEMOPOIETIC COLONY-FORMING CELLS OF MICE.

Authors:  W R BRUCE; E A MCCULLOCH
Journal:  Blood       Date:  1964-02       Impact factor: 22.113

2.  In vitro induction of myeloid proliferation and maturation in infantile genetic agranulocytosis.

Authors:  Y Barak; M Paran; S Levin; L Sachs
Journal:  Blood       Date:  1971-07       Impact factor: 22.113

3.  The growth of mouse bone marrow cells in vitro.

Authors:  T R Bradley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

4.  N.B.T. test on monocytes of neutropenic patients.

Authors:  B H Park; W D Biggar; P L'Esperance; R A Good
Journal:  Lancet       Date:  1972-05-13       Impact factor: 79.321

5.  Human leukemic cells: in vitro growth of colonies containing the Philadelphia (Ph) chromosome.

Authors:  P A Chervenick; L D Ellis; S F Pan; A L Lawson
Journal:  Science       Date:  1971-12-10       Impact factor: 47.728

6.  Clony growth of human peripherl white blood cells in vitro.

Authors:  J E Kurnick; W A Robison
Journal:  Blood       Date:  1971-02       Impact factor: 22.113

7.  In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals.

Authors:  P A Chervenick; D R Boggs
Journal:  Blood       Date:  1971-02       Impact factor: 22.113

8.  Purification and characterisation of the in vitro colony forming cell in monkey hemopoietic tissue.

Authors:  M A Moore; N Williams; D Metcalf
Journal:  J Cell Physiol       Date:  1972-04       Impact factor: 6.384

9.  Cells capable of colony formation in the peripheral blood of man.

Authors:  K B McCredie; E M Hersh; E J Freireich
Journal:  Science       Date:  1971-01-22       Impact factor: 47.728

10.  In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients.

Authors:  M Paran; L Sachs; Y Barak; P Resnitzky
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

View more
  3 in total

1.  Glycogenosis type Ib complicated by severe granulocytopenia resembling inherited neutropenia.

Authors:  C R Bartram; H Przyrembel; U Wendel; H J Bremer; J Schaub; J R Haas
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

2.  Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells.

Authors:  Ramesh C Nayak; Lisa R Trump; Bruce J Aronow; Kasiani Myers; Parinda Mehta; Theodosia Kalfa; Ashley M Wellendorf; C Alexander Valencia; Patrick J Paddison; Marshall S Horwitz; H Leighton Grimes; Carolyn Lutzko; Jose A Cancelas
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

3.  CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.

Authors:  Ngoc Tung Tran; Robin Graf; Annika Wulf-Goldenberg; Maria Stecklum; Gabriele Strauß; Ralf Kühn; Christine Kocks; Klaus Rajewsky; Van Trung Chu
Journal:  Mol Ther       Date:  2020-08-08       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.